Blueprint Medicines Quarterly Balance Sheets Chart
Quarterly
|
Annual
Blueprint Medicines Quarterly Balance Sheets Table
Quarterly
|
Annual
| Unit: USD | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| assets | |||||||||||||||||||||||||||||||||||||||||
| current assets: | |||||||||||||||||||||||||||||||||||||||||
| cash and cash equivalents | 122,245,000 | 102,014,000 | 89,356,000 | 54,771,000 | 113,326,000 | 71,286,000 | 55,972,000 | 75,527,000 | 169,724,000 | 119,709,000 | 291,430,000 | 173,399,000 | 37,199,000 | 209,948,000 | 553,593,000 | 534,317,000 | 697,966,000 | 684,636,000 | 565,221,000 | 288,678,000 | 375,168,000 | 113,938,000 | 89,237,000 | 82,425,000 | 79,391,000 | 68,064,000 | 78,641,000 | 117,751,000 | 134,886,000 | 400,304,000 | 57,329,000 | 91,346,000 | 56,356,000 | 52,069,000 | 74,403,000 | 109,386,000 | 122,289,000 | 162,707,000 | 179,780,000 | 193,587,000 | 50,298,000 |
| marketable securities | 453,992,000 | 513,473,000 | 644,817,000 | 708,831,000 | 534,575,000 | 639,355,000 | 657,012,000 | 647,107,000 | 652,437,000 | 825,283,000 | 845,535,000 | 679,712,000 | 549,627,000 | 267,166,000 | 148,285,000 | 94,032,000 | 187,213,000 | ||||||||||||||||||||||||
| accounts receivable | 78,083,000 | 75,797,000 | 65,814,000 | 85,058,000 | 60,047,000 | 42,827,000 | 40,861,000 | 35,147,000 | 30,007,000 | 23,525,000 | 19,320,000 | 27,123,000 | 28,758,000 | 25,155,000 | 18,400,000 | 25,473,000 | 34,662,000 | 7,096,000 | 44,369,000 | 3,403,000 | 4,510,000 | 663,000 | 2,414,000 | 750,000 | |||||||||||||||||
| unbilled accounts receivable | 1,718,000 | 1,812,000 | 351,000 | 393,000 | 3,120,000 | 1,296,000 | 13,413,000 | 2,595,000 | 2,287,000 | 3,840,000 | 11,875,000 | 11,324,000 | 13,767,000 | 9,201,000 | 18,213,000 | 16,887,000 | 20,877,000 | 20,597,000 | 22,749,000 | 2,662,000 | 4,514,000 | 3,435,000 | 3,075,000 | 2,826,000 | 3,455,000 | 3,351,000 | 4,232,000 | 3,414,000 | 2,470,000 | 1,923,000 | 484,000 | ||||||||||
| inventory | 12,953,000 | 13,611,000 | 12,528,000 | 14,789,000 | 30,940,000 | 21,223,000 | 16,457,000 | 17,016,000 | 17,521,000 | 29,697,000 | 35,253,000 | 35,454,000 | 30,145,000 | 21,817,000 | 16,570,000 | 15,211,000 | 16,030,000 | 8,581,000 | 5,565,000 | 4,359,000 | 2,665,000 | ||||||||||||||||||||
| prepaid expenses and other current assets | 33,078,000 | 35,971,000 | 42,333,000 | 40,095,000 | 37,714,000 | 33,351,000 | 37,477,000 | 33,418,000 | 29,359,000 | 35,024,000 | 33,532,000 | 34,204,000 | 37,675,000 | 18,064,000 | 23,676,000 | 21,270,000 | 25,856,000 | 22,020,000 | 17,404,000 | 17,875,000 | 10,147,000 | 9,820,000 | 15,208,000 | 14,827,000 | 10,660,000 | 5,775,000 | 6,021,000 | 8,757,000 | 8,373,000 | 6,192,000 | 7,239,000 | 4,736,000 | 3,449,000 | 2,216,000 | 1,928,000 | 4,176,000 | 6,218,000 | 5,814,000 | 1,279,000 | ||
| total current assets | 702,069,000 | 742,678,000 | 854,848,000 | 903,544,000 | 776,602,000 | 808,393,000 | 808,172,000 | 811,335,000 | 900,344,000 | 1,046,651,000 | 1,227,665,000 | 952,179,000 | 687,244,000 | 554,025,000 | 771,848,000 | 704,070,000 | 937,710,000 | 927,759,000 | 841,655,000 | 568,312,000 | 704,683,000 | 516,786,000 | 513,726,000 | 612,952,000 | 426,516,000 | 499,787,000 | 565,657,000 | 622,213,000 | 615,698,000 | 400,279,000 | 431,328,000 | 213,958,000 | 159,448,000 | 178,120,000 | 197,667,000 | 170,416,000 | 188,587,000 | 201,443,000 | 52,180,000 | ||
| property and equipment | 36,050,000 | 36,593,000 | 37,850,000 | 40,167,000 | 41,947,000 | 41,959,000 | 40,619,000 | 36,957,000 | 33,741,000 | 33,344,000 | 33,454,000 | 32,987,000 | 31,110,000 | 30,700,000 | 31,204,000 | 31,848,000 | 32,991,000 | 34,129,000 | 35,199,000 | 36,745,000 | 37,822,000 | 38,361,000 | 38,310,000 | 33,525,000 | 30,615,000 | 29,627,000 | 29,720,000 | 30,250,000 | 29,074,000 | 13,416,000 | 7,774,000 | 6,081,000 | 6,578,000 | 6,565,000 | 6,537,000 | 6,661,000 | 4,805,000 | 1,393,000 | 1,295,000 | ||
| operating lease right-of-use assets | 61,607,000 | 64,181,000 | 66,416,000 | 68,881,000 | 71,222,000 | 73,691,000 | 75,221,000 | 77,529,000 | 79,668,000 | 81,854,000 | 83,917,000 | 86,033,000 | 88,119,000 | 90,162,000 | 62,986,000 | 64,446,000 | 65,987,000 | 67,539,000 | 69,020,000 | 70,471,000 | 71,903,000 | 72,753,000 | 73,967,000 | 75,255,000 | 76,528,000 | ||||||||||||||||
| restricted cash | 11,847,000 | 11,625,000 | 11,503,000 | 10,623,000 | 10,634,000 | 10,238,000 | 9,696,000 | 6,352,000 | 5,207,000 | 5,195,000 | 5,193,000 | 5,171,000 | 5,171,000 | 5,171,000 | 5,171,000 | 5,171,000 | 5,171,000 | 5,168,000 | 5,168,000 | 5,168,000 | 5,168,000 | 5,166,000 | 5,164,000 | 5,161,000 | 5,159,000 | 5,154,000 | 5,154,000 | 4,557,000 | 4,557,000 | 4,767,000 | 4,767,000 | 1,267,000 | 119,000 | 119,000 | 119,000 | 119,000 | |||||
| equity investment | 28,699,000 | 28,699,000 | 27,789,000 | 27,789,000 | 27,789,000 | 27,789,000 | 27,789,000 | 27,789,000 | 27,789,000 | 27,789,000 | |||||||||||||||||||||||||||||||
| other assets | 60,484,000 | 47,587,000 | 52,153,000 | 47,687,000 | 22,578,000 | 30,650,000 | 29,560,000 | 32,551,000 | 34,471,000 | 21,589,000 | 24,699,000 | 22,028,000 | 25,138,000 | 14,638,000 | 14,193,000 | 11,558,000 | 5,360,000 | 5,925,000 | 8,666,000 | 8,286,000 | 10,381,000 | 10,222,000 | 5,741,000 | 5,887,000 | 5,845,000 | 5,556,000 | 5,579,000 | 4,898,000 | 1,341,000 | 1,656,000 | 852,000 | 1,413,000 | 557,000 | 569,000 | 540,000 | 555,000 | 560,000 | 36,000 | 1,099,000 | ||
| total assets | 1,195,604,000 | 1,179,813,000 | 1,199,649,000 | 1,203,560,000 | 1,038,475,000 | 1,049,250,000 | 1,105,299,000 | 1,106,445,000 | 1,220,370,000 | 1,349,902,000 | 1,458,392,000 | 1,192,446,000 | 1,143,307,000 | 1,252,225,000 | 1,477,322,000 | 1,568,795,000 | 1,625,387,000 | 1,718,393,000 | 1,558,178,000 | 817,457,000 | 913,623,000 | 707,694,000 | 737,925,000 | 807,178,000 | 544,663,000 | 540,124,000 | 606,110,000 | 665,113,000 | 664,468,000 | 715,737,000 | 420,118,000 | 444,721,000 | 252,648,000 | 282,795,000 | 167,849,000 | 186,520,000 | 206,010,000 | 178,898,000 | 195,288,000 | 204,208,000 | 55,910,000 |
| liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||
| current liabilities: | |||||||||||||||||||||||||||||||||||||||||
| accounts payable | 800,000 | 6,790,000 | 4,716,000 | 4,858,000 | 4,926,000 | 4,710,000 | 6,963,000 | 6,979,000 | 10,563,000 | 2,729,000 | 4,233,000 | 15,053,000 | 17,961,000 | 8,333,000 | 9,549,000 | 1,847,000 | 2,889,000 | 4,370,000 | 2,929,000 | 5,591,000 | 8,468,000 | 4,793,000 | 2,203,000 | 6,608,000 | 4,421,000 | 3,298,000 | 3,988,000 | 2,980,000 | 3,288,000 | 2,092,000 | 2,581,000 | 2,282,000 | 1,848,000 | 2,730,000 | 2,773,000 | 2,455,000 | 1,562,000 | 1,611,000 | 2,334,000 | ||
| accrued expenses | 122,055,000 | 133,088,000 | 130,881,000 | 120,539,000 | 107,277,000 | 127,992,000 | 110,436,000 | 101,162,000 | 108,735,000 | 131,123,000 | 120,763,000 | 119,282,000 | 100,698,000 | 121,829,000 | 94,540,000 | 107,173,000 | 86,479,000 | 105,938,000 | 89,116,000 | 84,062,000 | 73,961,000 | 88,706,000 | 80,419,000 | 64,126,000 | 50,826,000 | 51,711,000 | 45,181,000 | 39,808,000 | 29,087,000 | 23,797,000 | 17,396,000 | 10,346,000 | 7,410,000 | 7,607,000 | 5,335,000 | 6,436,000 | 7,809,000 | 4,038,000 | 4,404,000 | ||
| current portion of operating lease liabilities | 13,736,000 | 13,346,000 | 13,011,000 | 12,658,000 | 12,240,000 | 11,933,000 | 11,617,000 | 11,292,000 | 10,887,000 | 10,579,000 | 10,116,000 | 9,435,000 | 8,762,000 | 8,093,000 | 8,810,000 | 8,465,000 | 8,193,000 | 7,935,000 | 7,672,000 | 7,416,000 | 7,169,000 | 6,823,000 | 6,587,000 | 6,357,000 | 5,278,000 | ||||||||||||||||
| current portion of deferred revenue | 2,279,000 | 2,005,000 | 4,118,000 | 3,748,000 | 7,251,000 | 812,000 | 3,010,000 | 3,328,000 | 3,740,000 | 4,667,000 | 4,629,000 | 9,478,000 | 9,604,000 | 11,510,000 | 6,792,000 | 7,912,000 | 14,876,000 | 12,559,000 | 10,391,000 | 8,017,000 | 8,690,000 | 6,160,000 | 4,933,000 | 4,415,000 | 4,238,000 | 3,600,000 | 5,119,000 | 5,139,000 | 4,803,000 | 6,069,000 | 9,296,000 | 10,396,000 | 11,752,000 | 13,803,000 | 11,819,000 | 5,898,000 | 6,339,000 | 5,323,000 | 5,375,000 | ||
| current portion of liabilities related to the sale of future royalties and revenues | 67,917,000 | 61,650,000 | 59,903,000 | 53,741,000 | 44,729,000 | 39,198,000 | 35,137,000 | 28,410,000 | 21,377,000 | 17,285,000 | 20,479,000 | ||||||||||||||||||||||||||||||
| current portion of term loan | 43,797,000 | 43,917,000 | 45,032,000 | 48,259,000 | 30,180,000 | 30,278,000 | 30,221,000 | 17,857,000 | 17,382,000 | 16,851,000 | 15,290,000 | ||||||||||||||||||||||||||||||
| total current liabilities | 250,584,000 | 260,796,000 | 257,661,000 | 243,803,000 | 206,603,000 | 214,923,000 | 197,384,000 | 169,028,000 | 172,684,000 | 183,234,000 | 175,510,000 | 158,760,000 | 137,025,000 | 149,765,000 | 119,691,000 | 125,397,000 | 112,437,000 | 130,802,000 | 110,108,000 | 105,086,000 | 98,288,000 | 106,482,000 | 94,142,000 | 81,506,000 | 64,763,000 | 60,323,000 | 56,279,000 | 50,333,000 | 39,998,000 | 35,490,000 | 32,992,000 | 25,759,000 | 24,380,000 | 27,754,000 | 23,782,000 | 18,640,000 | 19,291,000 | 14,451,000 | 14,630,000 | ||
| operating lease liabilities, net of current portion | 65,216,000 | 68,790,000 | 71,916,000 | 75,244,000 | 78,489,000 | 81,751,000 | 84,036,000 | 87,049,000 | 89,940,000 | 92,789,000 | 95,495,000 | 98,160,000 | 100,762,000 | 103,315,000 | 75,054,000 | 77,272,000 | 79,477,000 | 81,669,000 | 83,735,000 | 85,727,000 | 87,667,000 | 89,126,000 | 90,921,000 | 92,646,000 | 94,322,000 | ||||||||||||||||
| deferred revenue, net of current portion | 8,037,000 | 8,193,000 | 7,916,000 | 8,041,000 | 4,635,000 | 4,792,000 | 5,000,000 | 5,000,000 | 5,000,000 | 13,624,000 | 11,995,000 | 12,661,000 | 13,721,000 | 25,066,000 | 28,605,000 | 30,365,000 | 26,097,000 | 28,599,000 | 35,017,000 | 36,688,000 | 36,809,000 | 39,913,000 | 36,398,000 | 40,055,000 | 41,198,000 | 42,567,000 | 42,081,000 | 43,156,000 | 34,931,000 | 30,703,000 | 32,109,000 | 33,824,000 | 39,595,000 | 39,249,000 | 44,948,000 | 7,742,000 | 8,522,000 | 10,495,000 | 9,457,000 | ||
| liabilities related to the sale of future royalties and revenues, net of current portion | 178,715,000 | 193,524,000 | 201,304,000 | 211,792,000 | 223,090,000 | 402,427,000 | 405,010,000 | 408,931,000 | 413,216,000 | 413,045,000 | 403,174,000 | ||||||||||||||||||||||||||||||
| term loan, net of current portion | 343,949,000 | 343,053,000 | 341,537,000 | 338,655,000 | 209,205,000 | 208,535,000 | 208,157,000 | 122,146,000 | 122,130,000 | 122,232,000 | 123,060,000 | ||||||||||||||||||||||||||||||
| other long-term liabilities | 6,972,000 | 6,792,000 | 6,167,000 | 5,784,000 | 5,766,000 | 6,213,000 | 3,101,000 | 3,161,000 | 3,102,000 | 10,301,000 | 8,851,000 | 9,373,000 | 10,133,000 | 3,344,000 | 6,885,000 | 6,957,000 | 7,355,000 | 7,235,000 | 9,318,000 | 8,589,000 | 7,928,000 | 7,814,000 | 120,000 | 144,000 | 167,000 | 192,000 | |||||||||||||||
| total liabilities | 853,473,000 | 881,148,000 | 886,501,000 | 883,319,000 | 727,788,000 | 918,641,000 | 902,688,000 | 795,315,000 | 806,072,000 | 835,225,000 | 818,085,000 | 444,696,000 | 261,641,000 | 281,490,000 | 230,235,000 | 239,991,000 | 225,366,000 | 248,305,000 | 238,178,000 | 236,090,000 | 230,692,000 | 243,335,000 | 221,581,000 | 214,351,000 | 200,450,000 | 121,115,000 | 116,814,000 | ||||||||||||||
| commitments and contingencies | |||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding | |||||||||||||||||||||||||||||||||||||||||
| common stock | 65,000 | 64,000 | 63,000 | 63,000 | 63,000 | 61,000 | 61,000 | 61,000 | 60,000 | 60,000 | 60,000 | 60,000 | 60,000 | 59,000 | 59,000 | 59,000 | 58,000 | 58,000 | 56,000 | 54,000 | 54,000 | 49,000 | 49,000 | 49,000 | 44,000 | 44,000 | 44,000 | 44,000 | 44,000 | 39,000 | 39,000 | 33,000 | 27,000 | 27,000 | 27,000 | 27,000 | 27,000 | 27,000 | 2,000 | ||
| additional paid-in capital | 2,751,838,000 | 2,709,183,000 | 2,671,231,000 | 2,624,868,000 | 2,565,277,000 | 2,473,985,000 | 2,434,258,000 | 2,410,601,000 | 2,381,358,000 | 2,358,018,000 | 2,329,385,000 | 2,303,087,000 | 2,275,156,000 | 2,250,250,000 | 2,209,456,000 | 2,174,094,000 | 2,136,130,000 | 2,106,600,000 | 1,867,572,000 | 1,762,099,000 | 1,739,140,000 | 1,412,083,000 | 1,394,566,000 | 1,376,484,000 | 1,029,046,000 | 1,016,690,000 | 1,006,812,000 | 997,770,000 | 988,872,000 | 647,928,000 | 643,223,000 | 423,750,000 | 283,862,000 | 281,853,000 | 280,080,000 | 278,927,000 | 277,515,000 | 276,320,000 | 3,691,000 | ||
| accumulated other comprehensive loss | -3,237,000 | -3,551,000 | -1,070,000 | -3,890,000 | -3,847,000 | -3,495,000 | -2,683,000 | -4,221,000 | -4,602,000 | -10,443,000 | -14,826,000 | -14,248,000 | -12,110,000 | -4,133,000 | -5,673,000 | -5,835,000 | -5,097,000 | -5,214,000 | -1,940,000 | -1,120,000 | -69,000 | -2,535,000 | -180,000 | -337,000 | -381,000 | -591,000 | -165,000 | -314,000 | -114,000 | ||||||||||||
| accumulated deficit | -2,406,535,000 | -2,407,031,000 | -2,357,076,000 | -2,300,800,000 | -2,250,806,000 | -2,339,942,000 | -2,229,025,000 | -2,095,311,000 | -1,962,518,000 | -1,832,958,000 | -1,674,312,000 | -1,541,149,000 | -1,381,440,000 | -1,275,441,000 | -956,755,000 | -839,514,000 | -731,070,000 | -631,356,000 | -545,688,000 | -1,179,666,000 | -1,056,194,000 | -945,238,000 | -878,908,000 | -784,633,000 | -684,952,000 | -597,545,000 | -517,223,000 | -444,501,000 | -417,452,000 | -306,562,000 | -268,859,000 | -235,447,000 | -186,206,000 | -169,373,000 | -150,479,000 | -134,975,000 | -119,400,000 | -106,758,000 | -93,778,000 | ||
| total stockholders’ equity | 342,131,000 | 298,665,000 | 313,148,000 | 320,241,000 | 310,687,000 | 130,609,000 | 202,611,000 | 311,130,000 | 414,298,000 | 514,677,000 | 640,307,000 | 747,750,000 | 881,666,000 | 970,735,000 | 1,247,087,000 | 1,328,804,000 | 1,400,021,000 | 1,470,088,000 | 1,320,000,000 | 581,367,000 | 682,931,000 | 464,359,000 | 516,344,000 | 592,827,000 | 344,213,000 | 419,009,000 | 489,296,000 | 552,932,000 | 570,873,000 | 623,970,000 | 341,240,000 | 374,089,000 | 188,222,000 | 213,078,000 | 97,710,000 | 112,562,000 | 129,659,000 | 143,979,000 | 158,142,000 | 169,589,000 | |
| total liabilities and stockholders’ equity | 1,195,604,000 | 1,179,813,000 | 1,199,649,000 | 1,203,560,000 | 1,038,475,000 | 1,049,250,000 | 1,105,299,000 | 1,106,445,000 | 1,220,370,000 | 1,349,902,000 | 1,458,392,000 | 1,192,446,000 | 1,143,307,000 | 1,252,225,000 | 1,477,322,000 | 1,568,795,000 | 1,625,387,000 | 1,718,393,000 | 1,558,178,000 | 817,457,000 | 913,623,000 | 707,694,000 | 737,925,000 | 807,178,000 | 544,663,000 | 540,124,000 | 606,110,000 | 665,113,000 | 664,468,000 | 420,118,000 | 444,721,000 | 252,648,000 | 167,849,000 | 186,520,000 | 206,010,000 | ||||||
| liability related to the sale of future royalties | 5,512,000 | ||||||||||||||||||||||||||||||||||||||||
| liability related to the sale of future royalties, net of current portion | 165,742,000 | ||||||||||||||||||||||||||||||||||||||||
| commitments | |||||||||||||||||||||||||||||||||||||||||
| investments, available-for-sale | 153,995,000 | 192,209,000 | 233,120,000 | 291,596,000 | 369,616,000 | 404,205,000 | 510,436,000 | 336,465,000 | 425,948,000 | 480,995,000 | 495,705,000 | 472,439,000 | 333,323,000 | 329,668,000 | 150,040,000 | 78,141,000 | 63,167,000 | 69,218,000 | |||||||||||||||||||||||
| current portion of lease incentive obligation | 1,714,000 | 1,714,000 | 1,714,000 | 1,714,000 | 1,714,000 | 1,714,000 | 578,000 | 578,000 | 578,000 | 578,000 | 578,000 | 578,000 | 578,000 | ||||||||||||||||||||||||||||
| deferred rent, net of current portion | 5,130,000 | 4,906,000 | 4,648,000 | 4,389,000 | 3,866,000 | 1,659,000 | 924,000 | 920,000 | 894,000 | 868,000 | 842,000 | 705,000 | 101,000 | ||||||||||||||||||||||||||||
| lease incentive obligation, net of current portion | 12,903,000 | 13,332,000 | 13,760,000 | 14,189,000 | 8,186,000 | 3,005,000 | 2,648,000 | 2,937,000 | 3,081,000 | 3,226,000 | 3,370,000 | 3,515,000 | 3,659,000 | ||||||||||||||||||||||||||||
| | |||||||||||||||||||||||||||||||||||||||||
| accumulated other comprehensive income | 637,000 | 927,000 | 75,000 | 27,000 | 55,000 | 31,000 | |||||||||||||||||||||||||||||||||||
| current portion of term loan payable | 277,000 | 692,000 | 1,106,000 | 1,818,000 | 1,979,000 | 2,140,000 | 2,792,000 | 3,033,000 | 3,272,000 | 3,266,000 | 2,978,000 | 2,552,000 | 2,127,000 | ||||||||||||||||||||||||||||
| other long term liabilities | 216,000 | 284,000 | 88,000 | 356,000 | 175,000 | 165,000 | 211,000 | 308,000 | 281,000 | 252,000 | 219,000 | 184,000 | 147,000 | ||||||||||||||||||||||||||||
| balance sheet data: | |||||||||||||||||||||||||||||||||||||||||
| investments | 273,052,000 | 216,149,000 | |||||||||||||||||||||||||||||||||||||||
| working capital | 642,615,000 | 191,913,000 | |||||||||||||||||||||||||||||||||||||||
| deferred revenue | 35,373,000 | 47,235,000 | |||||||||||||||||||||||||||||||||||||||
| term loan payable | 1,518,000 | 4,069,000 | |||||||||||||||||||||||||||||||||||||||
| warrant liability | 403,000 | ||||||||||||||||||||||||||||||||||||||||
| convertible preferred stock | |||||||||||||||||||||||||||||||||||||||||
| term loan payable, net of current portion | 277,000 | 692,000 | 1,106,000 | 2,095,000 | 2,672,000 | 3,246,000 | 4,072,000 | 4,893,000 | 5,710,000 | 6,525,000 | |||||||||||||||||||||||||||||||
| current portion of deferred rent | 26,000 | 17,000 | |||||||||||||||||||||||||||||||||||||||
| restricted stock liability | 3,000 | 5,000 | 7,000 | 9,000 | 291,000 | 292,000 | |||||||||||||||||||||||||||||||||||
| restricted stock liability, net of current portion | 1,000 | 1,000 | 1,000 | 19,000 | 25,000 | ||||||||||||||||||||||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||
| deferred rent | 16,000 | 58,000 | 98,000 | ||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value: no shares and 40,150,000 shares authorized at december 31, 2015 and december 31, 2014, respectively; no shares and 40,000,000 shares issued and outstanding at december 31, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock, 0.001 par value: no shares and 20,999,996 shares authorized at december 31,2015 and december 31, 2014, respectively; no shares and 20,916,663 shares issued and outstanding at december 31, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| series c convertible preferred stock, 0.001 par value: no shares and 24,154,589 shares authorized at december 31, 2015 and december 31, 2014, respectively; no shares and 24,154,589 shares issued and outstanding at december 31, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding at december 31, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ equity | 178,898,000 | 195,288,000 | 204,208,000 | ||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value: 0 and 40,150,000 shares authorized at september 30, 2015 and december 31, 2014, respectively; 0 and 40,000,000 shares issued and outstanding at september 30, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock, 0.001 par value: 0 and 20,999,996 shares authorized at september 30,2015 and december 31, 2014, respectively; 0 and 20,916,663 shares issued and outstanding at september 30, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| series c convertible preferred stock, 0.001 par value: 0 and 24,154,589 shares authorized at september 30, 2015 and december 31, 2014, respectively; 0 and 24,154,589 shares issued and outstanding at september 30, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding at september 30, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value: 0 and 40,150,000 shares authorized at june 30, 2015 and december 31, 2014, respectively; 0 and 40,000,000 shares issued and outstanding at june 30, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock, 0.001 par value: 0 and 20,999,996 shares authorized at june 30,2015 and december 31, 2014, respectively; 0 and 20,916,663 shares issued and outstanding at june 30, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| series c convertible preferred stock, 0.001 par value: 0 and 24,154,589 shares authorized at june 30, 2015 and december 31, 2014, respectively; 0 and 24,154,589 shares issued and outstanding at june 30, 2015 and december 31, 2014, respectively | |||||||||||||||||||||||||||||||||||||||||
| preferred stock, 0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding at june 30, 2015 and december 31, 2014 | |||||||||||||||||||||||||||||||||||||||||
| liabilities, convertible preferred stock and stockholders’ (deficit) equity | |||||||||||||||||||||||||||||||||||||||||
| series a convertible preferred stock, 0.001 par value: 40,150,000 shares authorized; 40,000,000 shares issued and outstanding at march 31, 2015 and december 31, 2014 | 39,958,000 | ||||||||||||||||||||||||||||||||||||||||
| series b convertible preferred stock, 0.001 par value: 20,999,996 shares authorized; 20,916,663 shares issued and outstanding at march 31, 2015 and december 31, 2014 | 24,985,000 | ||||||||||||||||||||||||||||||||||||||||
| series c convertible preferred stock, 0.001 par value: 24,154,589 shares authorized; 24,154,589 shares issued and outstanding at march 31, 2015 and december 31, 2014 | 49,865,000 | ||||||||||||||||||||||||||||||||||||||||
| stockholders’ deficit: | |||||||||||||||||||||||||||||||||||||||||
| total stockholders’ deficit | -90,085,000 | ||||||||||||||||||||||||||||||||||||||||
| total liabilities, convertible preferred stock, and stockholders’ deficit | 55,910,000 |
We provide you with 20 years of balance sheets for Blueprint Medicines stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Blueprint Medicines. Explore the full financial landscape of Blueprint Medicines stock with our expertly curated balance sheets.
The information provided in this report about Blueprint Medicines stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.